JPWO2021247567A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021247567A5 JPWO2021247567A5 JP2022573756A JP2022573756A JPWO2021247567A5 JP WO2021247567 A5 JPWO2021247567 A5 JP WO2021247567A5 JP 2022573756 A JP2022573756 A JP 2022573756A JP 2022573756 A JP2022573756 A JP 2022573756A JP WO2021247567 A5 JPWO2021247567 A5 JP WO2021247567A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- adenoviral vector
- composition
- coronavirus
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032815P | 2020-06-01 | 2020-06-01 | |
| US63/032,815 | 2020-06-01 | ||
| US202063051103P | 2020-07-13 | 2020-07-13 | |
| US63/051,103 | 2020-07-13 | ||
| US202163162417P | 2021-03-17 | 2021-03-17 | |
| US63/162,417 | 2021-03-17 | ||
| PCT/US2021/035239 WO2021247567A1 (en) | 2020-06-01 | 2021-06-01 | Coronavirus vaccine constructs and methods of making and using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023529124A JP2023529124A (ja) | 2023-07-07 |
| JP2023529124A5 JP2023529124A5 (https=) | 2024-06-07 |
| JPWO2021247567A5 true JPWO2021247567A5 (https=) | 2024-06-07 |
Family
ID=78829898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573756A Pending JP2023529124A (ja) | 2020-06-01 | 2021-06-01 | コロナウイルスワクチンコンストラクトおよびこれを作製し使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230227848A1 (https=) |
| EP (1) | EP4157347A4 (https=) |
| JP (1) | JP2023529124A (https=) |
| KR (1) | KR20230033650A (https=) |
| AU (1) | AU2021285823A1 (https=) |
| CA (1) | CA3180064A1 (https=) |
| WO (1) | WO2021247567A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023133227A2 (en) * | 2022-01-06 | 2023-07-13 | Board Of Regents, The University Of Texas System | A sars-cov-2 human parainfluenza virus type 3-vectored vaccine |
| KR20240137110A (ko) * | 2022-02-02 | 2024-09-19 | 워싱턴 유니버시티 | 오미크론 코로나바이러스 백신 구조체 및 이를 제조하고 사용하는 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2716928C (en) * | 2008-03-04 | 2018-04-10 | The Trustees Of The University Of Pennsylvania | Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof |
| EP4599847A3 (en) * | 2016-10-25 | 2025-11-12 | Trustees of Dartmouth College | Prefusion coronavirus spike proteins and their use |
| CN111088283B (zh) * | 2020-03-20 | 2020-06-23 | 苏州奥特铭医药科技有限公司 | mVSV病毒载体及其病毒载体疫苗、一种基于mVSV介导的新冠肺炎疫苗 |
-
2021
- 2021-06-01 WO PCT/US2021/035239 patent/WO2021247567A1/en not_active Ceased
- 2021-06-01 EP EP21817848.1A patent/EP4157347A4/en active Pending
- 2021-06-01 CA CA3180064A patent/CA3180064A1/en active Pending
- 2021-06-01 AU AU2021285823A patent/AU2021285823A1/en active Pending
- 2021-06-01 US US18/007,677 patent/US20230227848A1/en active Pending
- 2021-06-01 JP JP2022573756A patent/JP2023529124A/ja active Pending
- 2021-06-01 KR KR1020227044997A patent/KR20230033650A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111088283A (zh) | mVSV病毒载体及其病毒载体疫苗、一种基于mVSV介导的新冠肺炎疫苗 | |
| EP3804751A2 (en) | Adenovirus carrier vaccine used for preventing sars-cov-2 infection | |
| JPWO2021155323A5 (https=) | ||
| JP2025184979A5 (https=) | ||
| JP2020511940A5 (https=) | ||
| CN114150004A (zh) | 表达SARS-CoV-2奥密克戎突变株病毒抗原肽的核酸序列及其应用 | |
| CN113444156B (zh) | 新型冠状病毒肺炎重组人5型腺病毒疫苗 | |
| WO2021220246A1 (en) | Recombinant sars-cov-2 polypeptides and uses | |
| CN112220918B (zh) | 一种用于预防SARS-CoV-2感染的Ad35载体疫苗 | |
| JPWO2021163622A5 (https=) | ||
| JPWO2021154828A5 (https=) | ||
| BR112020012273A2 (pt) | métodos e composições para induzir uma resposta imune contra o vírus da hepatite b (hbv) | |
| JP2025084850A (ja) | ハンタウイルス抗原性組成物 | |
| JP2009544303A5 (https=) | ||
| JP2021518152A5 (https=) | ||
| JPWO2021247567A5 (https=) | ||
| CN118126141B (zh) | 一种表达猪瘟病毒突变的全长e2蛋白的重组伪狂犬病毒株及应用 | |
| US11413345B2 (en) | Synthetic hemagglutinin as universal vaccine against infection by type B influenza viruses (IBV) | |
| JPWO2023150638A5 (https=) | ||
| WO2023202711A1 (zh) | 一种基于新型冠状病毒的mRNA疫苗 | |
| JP2003528812A (ja) | Ｒｓｖの免疫原性ペプチドと組み合わせた腸内細菌ｏｍｐａ膜タンパク質の経鼻投与可能なワクチンの製造のための使用 | |
| KR102616012B1 (ko) | 당화된 돼지 인터페론-알파를 발현하는 재조합 베큘로바이러스 | |
| US20240366752A1 (en) | Vaccine composition for prevention against covid-19 | |
| JPWO2022010813A5 (https=) | ||
| EP3922263A1 (en) | Ad7 vector vaccine for preventing sars-cov-2 infection |